Protective Effects of Hydrogen Sulphide Against Renal Ischemia Reperfusion Injury During Allogeneic Renal Transplantation

硫化氢对同种异体肾移植肾缺血再灌注损伤的保护作用

• 批准号: 307722
• 负责人: Lobb Ian
• 金额: $ 7.65万
• 依托单位: University of Western Ontario
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-10-01 至 2016-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=307722&lang=en
• 关键词: Elisa; Graft Rejection; Hydrogen Sulphide; Inflammatory Response; Ischemia Reperfusion Injury; Kidney Transplantation; Mixed Lymphocyte Reaction; Organ Preservation; Transplantation Immunology; Western Blot

End stage renal disease (ESRD) is a highly prevalent disease and its best treatment course is kidney transplantation. However, transplantation is inherently complicated by organ damage caused by ischemia-reperfusion injury (IRI), resulting from necessary

终末期肾病（ESRD）是一种高度流行的疾病，其最佳治疗方案是肾移植。然而，移植固有地被由缺血再灌注损伤（IRI）引起的器官损伤复杂化，所述缺血再灌注损伤是由必要的缺血再灌注损伤（IRI）引起的。